GLP-1 weight-loss drug, whose full name is Glucagon-like peptide-1 receptor agonist. Initially, GLP-1 was a hormone secreted by the gastrointestinal tract mainly used for treating diabetes, but it has also been used to suppress appetite and control weight.
Here Are Morgan Stanley's Key Oncology Catalysts for 2025
Eli Lilly to End 2024 Among Best in Big Pharma; Novo Among Worst
Elon Musk Admits To Using Weight Loss Medication Criticized By RFK Jr, Says He Prefers Mounjaro Over Miracle Drug Ozempic
Weekly Buzz: So far, Santa is Letting us Down
Looking At Amgen's Recent Unusual Options Activity
Most Shorted Stocks on Wall Street Heading Into 2025: BYND, KSS, GRPN, and More
Nail E Got G OP : In January 2025, the potential Penny Stocks in the US worth paying attention to:
1. Airship AI (AISP): Focuses on AI solutions with great market potential.
2. Vuzix (VUZI): Develops Augmented Reality (AR) glasses, benefiting from AR market growth.
3. GeoVox Labs: Provides 3D geospatial technology, with increasing demand.
4. Cardiol Therapeutics (CRDL): Researching anti-inflammatory heart disease therapies, poised for clinical breakthroughs.
5. Ribbon Communications (RBBN): Communication software and network solutions are favored.
***High risk, high returns: Significant price fluctuations, requiring cautious investment.***